Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial. Lancet Gastroenterol Hepatol 2024 Aug;9(8):687
Date
07/07/2024
Pubmed ID
38971163DOI
10.1016/S2468-1253(24)00130-4Scopus ID
2-s2.0-85197058786 (requires institutional sign-in at Scopus site)
2 CitationsAuthor List
Westerhoff JM, Sanford NN, Hall WA
Author
William Adrian Hall MD Chair, Professor in the Radiation Oncology department at Medical College of Wisconsin